Biokarpet Balance Sheet Health
Financial Health criteria checks 3/6
Biokarpet has a total shareholder equity of €49.4M and total debt of €97.2M, which brings its debt-to-equity ratio to 196.8%. Its total assets and total liabilities are €209.3M and €159.9M respectively. Biokarpet's EBIT is €6.8M making its interest coverage ratio 1. It has cash and short-term investments of €7.2M.
Key information
196.8%
Debt to equity ratio
€97.24m
Debt
| Interest coverage ratio | 1x |
| Cash | €7.15m |
| Equity | €49.42m |
| Total liabilities | €159.91m |
| Total assets | €209.33m |
Recent financial health updates
Is Biokarpet (ATH:BIOKA) A Risky Investment?
Oct 03
Biokarpet (ATH:BIOKA) Seems To Be Using A Lot Of Debt
Oct 10Is Biokarpet (ATH:BIOKA) Using Too Much Debt?
Oct 21Recent updates
We Think That There Are More Issues For Biokarpet (ATH:BIOKA) Than Just Sluggish Earnings
Oct 07Is Biokarpet (ATH:BIOKA) A Risky Investment?
Oct 03The Return Trends At Biokarpet (ATH:BIOKA) Look Promising
Apr 13Biokarpet's (ATH:BIOKA) Returns On Capital Are Heading Higher
Nov 09Biokarpet (ATH:BIOKA) Seems To Be Using A Lot Of Debt
Oct 10Biokarpet S.A. (ATH:BIOKA) Doing What It Can To Lift Shares
Sep 09Biokarpet (ATH:BIOKA) Might Have The Makings Of A Multi-Bagger
Jul 11Biokarpet (ATH:BIOKA) Is Doing The Right Things To Multiply Its Share Price
Mar 23Do Biokarpet's (ATH:BIOKA) Earnings Warrant Your Attention?
Sep 14Here's Why I Think Biokarpet (ATH:BIOKA) Is An Interesting Stock
Jun 04Investors Will Want Biokarpet's (ATH:BIOKA) Growth In ROCE To Persist
Dec 09Is Biokarpet (ATH:BIOKA) Using Too Much Debt?
Oct 21Biokarpet (ATH:BIOKA) Is Experiencing Growth In Returns On Capital
Jun 03Does Biokarpet (ATH:BIOKA) Have The Makings Of A Multi-Bagger?
Feb 23Financial Position Analysis
Short Term Liabilities: BIOKA's short term assets (€107.2M) exceed its short term liabilities (€61.8M).
Long Term Liabilities: BIOKA's short term assets (€107.2M) exceed its long term liabilities (€98.1M).
Debt to Equity History and Analysis
Debt Level: BIOKA's net debt to equity ratio (182.3%) is considered high.
Reducing Debt: BIOKA's debt to equity ratio has reduced from 262.3% to 196.8% over the past 5 years.
Debt Coverage: BIOKA's debt is not well covered by operating cash flow (3.4%).
Interest Coverage: BIOKA's interest payments on its debt are not well covered by EBIT (1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 07:23 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Biokarpet S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|